– UK, Uxbridge – Coca-Cola Europacific Partners plc (LON: CCEP / Euronext: CCEP / NASDAQ: CCEP) announced the appointment of Rob Appleby to its Board as an Independent Non-executive Director with effect from the AGM on 22 May 2025.
“I am delighted that Rob has agreed to join the CCEP Board. His diverse experience and in particular in the area of ESG given the ever evolving landscape and also his financial acumen will greatly support the Board and we welcome his appointment.” said Board Chairman, Sol Daurella.
About Robert Appleby
Rob Appleby brings to the Board strong financial and ESG expertise and experience in both Europe and Far East markets. He is the Founder and CIO at Cibus Capital, a food and agribusiness-focused private equity platform. Before founding Cibus, Rob Appleby was a co-founder and joint CIO of ADM Capital Hong Kong and Director of the ADM Capital Foundation. Before establishing ADM Capital, he held senior positions at Lehman Brothers and Credit Agricole, including working in the Far East.
About CCEP
Coca-Cola Europacific Partners is one of the world’s leading consumer goods companies. We make, move, and sell some of the world’s most loved brands – serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.
We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.
The Company is currently listed on Euronext Amsterdam, NASDAQ (and a constituent of the Nasdaq 100), the London Stock Exchange, and the Spanish Stock Exchanges, trading under the symbol CCEP.
For more: https://www.cocacolaep.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.